We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+9.87%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$138B
AUM Growth
+$12B
Cap. Flow
+$443M
Cap. Flow %
0.32%
Top 10 Hldgs %
18.35%
Holding
8,009
New
285
Increased
3,874
Reduced
2,887
Closed
270

Sector Composition

Rank Sector Weight
1 Technology 6.66%
2 Financials 5.43%
3 Healthcare 5.11%
4 Consumer Discretionary 4.43%
5 Communication Services 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIN icon
6101
Merchants Bancorp
MBIN
$2.55B
$58K ﹤0.01%
4,394
+1,346
+44% +$15.7K
MITK icon
6102
Mitek Systems
MITK
$771M
$58K ﹤0.01%
7,640
-15,074
-66% -$127K
MUA icon
6103
BlackRock MuniAssets Fund
MUA
$512M
$58K ﹤0.01%
3,801
+600
+19% +$9.19K
SYRE icon
6104
Spyre Therapeutics
SYRE
$8.81B
$58K ﹤0.01%
304
+199
+190% +$39.1K
FTCH
6105
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$58K ﹤0.01%
5,600
-800
-13% -$7.18K
AFMD
6106
DELISTED
Affimed
AFMD
$57K ﹤0.01%
2,063
+1,771
+607% +$47.4K
AOR icon
6107
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$57K ﹤0.01%
1,194
BTE icon
6108
Baytex Energy
BTE
$3.04B
$57K ﹤0.01%
39,935
+35,635
+829% +$44K
CECO icon
6109
Ceco Environmental
CECO
$3.83B
$57K ﹤0.01%
7,480
+2,088
+39% +$15.6K
IGA
6110
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
$57K ﹤0.01%
5,392
+90
+2% +$936
MNOV icon
6111
MediciNova
MNOV
$66M
$57K ﹤0.01%
8,412
+2,883
+52% +$21.7K
NKSH icon
6112
National Bankshares
NKSH
$253M
$57K ﹤0.01%
1,267
+346
+38% +$14.8K
RRBI icon
6113
Red River Bancshares
RRBI
$649M
$57K ﹤0.01%
1,013
+996
+5,859% +$47.4K
AKTS
6114
DELISTED
Akoustis Technologies Inc
AKTS
$57K ﹤0.01%
7,097
+5,852
+470% +$45.7K
AY
6115
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$57K ﹤0.01%
2,150
-2,750
-56% -$68.7K
PGNX
6116
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$57K ﹤0.01%
11,200
APYX icon
6117
Apyx Medical
APYX
$173M
$56K ﹤0.01%
6,675
+5,734
+609% +$41.4K
ARKK icon
6118
ARK Innovation ETF
ARKK
$5.77B
$56K ﹤0.01%
1,113
ATEC icon
6119
Alphatec Holdings
ATEC
$1.49B
$56K ﹤0.01%
7,836
+6,032
+334% +$38.7K
BUI icon
6120
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$727M
$56K ﹤0.01%
2,500
CRNX icon
6121
Crinetics Pharmaceuticals
CRNX
$8.85B
$56K ﹤0.01%
2,251
+1,067
+90% +$20.3K
HPI
6122
John Hancock Preferred Income Fund
HPI
$428M
$56K ﹤0.01%
2,450
IYLD icon
6123
iShares Morningstar Multi-Asset Income ETF
IYLD
$125M
$56K ﹤0.01%
2,173
+1,000
+85% +$25.1K
MCBS icon
6124
MetroCity Bankshares
MCBS
$1B
$56K ﹤0.01%
+3,184
New +$47.6K
MRSH
6125
PUT
Marsh
MRSH
$91.4B
$56K ﹤0.01%
500
-3,900
-89% -$407K

Similar funds

Citigroup's Q4 2019 Portfolio in Review

As of Q4 2019, Citigroup held 8,009 positions worth $138B, up 9.5% from $126B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Citigroup's Q4 2019 filing shows 285 new, 3,874 increased, 2,887 reduced and 270 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M. The largest sale was Celgene Corp, an estimated $749M.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q4 2019 buy was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M.
  • Citigroup added most to Invesco QQQ Trust in Q4 2019, an estimated $1.04B increase.
  • Citigroup's biggest Q4 2019 reduction was Alibaba, cutting an estimated $274M.
  • Citigroup fully exited Celgene Corp in Q4 2019, selling an estimated $749M.
  • Citigroup's ten largest holdings make up 18% of its $138B portfolio in Q4 2019.
  • Citigroup opened 285 new positions and closed 270 in Q4 2019.
  • Citigroup's portfolio value rose 9.5% quarter-over-quarter to $138B.

Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.